I think that you have shown again that you are a true champion for all farmers, all of agriculture, and I truly apprecia...
Well, name the program here and now. You know, go get 'em. You are on, man.
Do you have any technical response or thoughts to it?
We welcome Senator Brownback's recommendation to Administrator Shah to support the review process to shorten pathways fo...
Thank you very much for inviting me to testify today on interventions to combat rare and neglected diseases.
Thank you for your leadership on this. I know you've worked in the field, then got frustrated...
I'm frustrated, because I've been working in this space for 5 or 6 years, and I'm kind of, 'All right. Where's the produ...
I hope we can.
It's just not good enough. I know we can do better than this.
It's my hope that, in the future, when the good Samaritan story is told, it's the United States that's the one that stop...
It doesn't seem like we're getting there yet with rare and neglected diseases.
Less than 3 percent of the rare diseases have an FDA-approved treatment.
I wonder if you've surveyed some of the countries and places you're working, and ask them for the top 10 priorities that...
The old model of a billion dollars to develop a drug doesn't work in this category.
I think we should really look at a key issue, which is the economics of--you know, FDA and NIH can do all the work they ...
We are delighted that the Brownback-Brown provisions have led to initiatives, such as the Priority Review Voucher Progra...
I hope you can illuminate us on what's taking place, and what we can do to try to help out.
And I have noticed that a lot of key scientists around the world, some of the most cost-effective things we could do to ...
